Limit stock options to 60% of non-employee director equity awards
Deadline passed; outcome being checked
- Announced
- 5 Feb 2021
- Due
- 31 Dec 2025
- Status
- Checking
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“The Policy will provide that, through the Commitment Date, no more than 60% of each non-employee director’s annual and initial equity awards will be granted in the form of stock options.”
What we found
The deadline has passed. We check for public evidence starting 30 days after the deadline, and repeat the check if nothing clear turns up.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Other
- Indicative materiality
- Low rules
- Action
- Limit
- Deliverable
- non-employee director equity award policy
- Target
- 60 percent
- Language
- Firm (“will”, “on track to”)
- In the company’s control
- High
- Specificity
- High
- Conditional
- Yes: subject to Court approval
- Depends on
- Court
Tell me what happens
This deadline has not been settled yet. We check 30 days after it passes. Get an email when we record the outcome.
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- OutcomeNot yet assessed. Nothing is judged before the deadline.
Are you Denali Therapeutics Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-DNLI-023201 · Corrections policy